Navigation Links
Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time
Date:7/28/2011

/ul>

OTHER SECOND QUARTER DEVELOPMENTS


Acquisition of ABH  

  • On June 28, 2011 Shire announced that it had completed the acquisition of ABH for a cash purchase price of $739 million. A strong strategic fit for Shire, the ABH business becomes part of Shire's Specialty Pharmaceuticals ("SP") business. This acquisition combines ABH's experience and commercial capability in regenerative medicine with Shire's strengths and expertise in human cell biological manufacturing. It also creates a new strategic platform based on tissue regeneration using cell-based therapies and adds DERMAGRAFT, a leading US marketed product for DFU, to Shire's portfolio. There are also further growth prospects for DERMAGRAFT through a potential expanded indication for VLU.

Legal Proceedings

VYVANSE - for the treatment of ADHD

  • In May and June 2011, Shire was notified that six separate Abbreviated New Drug Applications ("ANDAs") were submitted under the Hatch-Waxman Act seeking permission to market generic versions of all approved strengths of VYVANSE. The notices were from Sandoz, Inc.; Amneal Pharmaceuticals LLC; Watson Laboratories, Inc.; Roxane Laboratories, Inc.; Mylan Pharmaceuticals, Inc.; and Actavis Elizabeth LLC and Actavis Inc. Within the requisite 45 day period, Shire filed lawsuits for infringement of certain of Shire's VYVANSE patents against all the ANDA filers. The filing of the lawsuits triggered a stay of approval of all six ANDAs for up to 30 months.

BOARD CHANGES

On July 27, 2011, Shire announced that Susan Kilsby will join the Shire Board of Directors from September 1, 2011.  On joining the Board Susan will become a member of the Company's Audit, Compliance and Risk Committee. Susan has a distinguished global career in investment banking, most recently with Credit Suisse, where she was Chairman of the EMEA Me
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. Neogen Reports 27% Increase in Quarterly Net Income
2. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
3. Microbix Has Best-Ever Quarterly Sales
4. Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled
5. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
6. Shires Replenished Portfolio Drives Excellent Quarterly Performance
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
9. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
10. Abbott Declares 343rd Consecutive Quarterly Dividend
11. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building ... 25 organizations will continue their work to increase awareness ... in daily life with the aid of SPIE ... 10 countries, are the first of two groups of ... the international society for optics and photonics , in ...
(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... , , SAN MARINO, Calif., ... scientist at biotechnology company Viral Genetics (Pink Sheets: VRAL), will ... Newell,s presentation entitled: "The Impact of Custom Peptides on Chronic ... The conference is being held at The Loews Santa Monica ...
... , DAEJEON, South Korea, Sept. 16 ... fully-human monoclonal antibodies for the treatment of cancer and inflammatory ... a Series A financing. OrbiMed,s Caduceus Asia Partners and ... from an international syndicate including Green Cross, Tong Yang and ...
... BEIJING, Sept. 16 /PRNewswire-Asia/ -- ... has announced it will broaden inclusion,criteria for its ... use,stem cells derived from peripheral blood to treat ... foot ulcers involves intensive,wound management, risk reduction and ...
Cached Biology Technology:Viral Genetics' Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference 2PharmAbcine Closes USD $6 Million Series A Financing 2PharmAbcine Closes USD $6 Million Series A Financing 3PharmAbcine Closes USD $6 Million Series A Financing 4Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 2Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 3Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 4
(Date:5/20/2013)... a compound abundant in the Mediterranean diet takes away ... altering a very specific step in gene regulation, this ... die as scheduled. , One way that cancer cells ... them to die on a regular cycle that is ... by Ohio State University researchers, found that a compound ...
(Date:5/20/2013)... Geology articles posted online ahead of ... wide swath of geoscience subdisciplines, including minerals exploration, ... Locations studied include Siberia; the Sumatran subduction margin; ... Ukraine; Mars; and the Southeastern U.S. Atlantic Margin. ... and plate tectonics;, 2. The clear fingerprint of ...
(Date:5/18/2013)... The AGA Research Foundation is honored to announce ... in Digestive Cancer, which will support Andrew D. Rhim, ... University of Pennsylvania, Philadelphia, as he furthers his research ... and cancer progression. , "The AGA Research Foundation is ... distinguished clinicians and AGA Legacy Society members," said Nicholas ...
Breaking Biology News(10 mins):The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... of bees and other pollinators is not, at this ... of an international study published in the latest edition ... , Co-author, CSIRO Entomology,s Dr Saul Cunningham, says ... for pollinators is still growing and some highly pollinator-dependant ...
... A team of researchers led by North Carolina State University ... devices and a host of other revolutionary medical implants. The ... material can be used to create new devices that can ... sensors for diabetics and artificial hemo-dialysis membranes that can scrub ...
... 156th Acoustical Society of America (ASA) meeting convenes next ... Spa in Miami. Reporters are invited to visit the ... On this site are posted news releases and ... 660 talks and posters. They relate to a cross-section ...
Cached Biology News:Pollinator decline not reducing crop yields just yet 2NC State finds new nanomaterial could be breakthrough for implantable medical devices 2The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 2The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 3The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 4
Ready-to-use solution....
ready-to-use solution...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Clone/PAD: ZMD.420. Immunogen: ... Specificity: Specific for the ... Reactivity: Human (positive control: ... Based on sequence homology reactivity ...
Biology Products: